Drug intelligence / Profile preview

Gulao Decoction

Development stage: Unknown
Lead developer: Nanjing Hospital of Integrated Traditional Chinese and Western Medicine
Administration: Oral

Overview

Gulao Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Nanjing Integrated Traditional Chinese and Western Medicine Hospital for the treatment of bone tuberculosis. It is designed to address immune dysregulation by modulating the balance between Th17 and Regulatory T (Treg) cells. Additionally, the decoction is utilized to mitigate liver damage induced by standard anti-tuberculosis chemotherapy, aiming to enhance therapeutic efficacy while reducing systemic toxicity.

Other names: tuberculosis soupGulao Tang

Beyond the preview

Go deeper on Gulao Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gulao Decoction.

Explore the full profile